Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Right Ventricular Dysfunction: early-phase trial registry

3 of 6 indexed Right Ventricular Dysfunction trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Right Ventricular Dysfunction: 6 US clinical trials tracked, 3 recruiting.

Right Ventricular Dysfunction is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is GE Healthcare, running 1 of these trials.

Enrollment posture brief

Registry condition right-ventricular-dysfunction

OPEN 3 | RECR 50% | LATE 1 | EARLY 2 | RANK #2866 | SPON 1

Nearest open-share peer: Achalasia (50% recruiting · 8 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Right Ventricular Dysfun (th…50%
Open-enrollment share among volume-matched conditions near Right Ventricular Dysfunction

Right Ventricular Dysfunction lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Right Ventricular Dysfunction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Right Ventricular Dysfunction is recruiting above its size-band peers.

    3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Right Ventricular Dysfunction research.

    GE Healthcare accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Most Right Ventricular Dysfunction trials plan to enrol fewer than 100 people.

    Median target enrolment is 60 among the 6 trials that report a genuine target (sentinel values excluded). 5 of those (83.3%) plan for fewer than 100 participants.

  4. Right Ventricular Dysfunction splits between interventional and observational designs.

    4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21Phase 41

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 4 1

Named interventions

Most-linked intervention names on Right Ventricular Dysfunction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

inhaled nebulized milrinone Drug
1 trials
Inhaled, nebulized, Milrinone Drug
1 trials
EKOS Device
1 trials
Alteplase Drug
1 trials
3D TEE Rvef Diagnostic test
1 trials
Valsartan 40 mg Drug
1 trials
Exercise training Behavioral
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Right Ventricular Dysfunction trials. A trial with sites in several states counts in each.

Washington 1 trials
Pennsylvania 1 trials
Oregon 1 trials
New York 1 trials
Nebraska 1 trials
Colorado 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Right Ventricular Dysfunction page

6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Right Ventricular Dysfunction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • GE Healthcare sponsors the most Right Ventricular Dysfunction trials on record, review their full trial history before evaluating a specific study. See GE Healthcare's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Right Ventricular Dysfunction condition card totals 6 registered trials; most-linked intervention inhaled nebulized milrinone; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.